A phase II study of tremelimumab (CP-675,206), an anti-CTLA4 monoclonal antibody, in patients with refractory metastatic colorectal cancer Meeting Abstract
| Authors: | Chung, K. Y.; Gore, I.; Fong, L.; Venook, A.; Beck, S. B.; Dorazio, P.; Criscitiello, P.; Healey, D. G.; Pavlov, D.; Saltz, L. B. |
| Abstract Title: | A phase II study of tremelimumab (CP-675,206), an anti-CTLA4 monoclonal antibody, in patients with refractory metastatic colorectal cancer |
| Meeting Title: | 22nd Annual Scientific Meeting of the International Society or Biological Therapy of Cancer |
| Journal Title: | Journal of Immunotherapy |
| Volume: | 30 |
| Issue: | 8 |
| Meeting Dates: | 2007 Nov 2-4 |
| Meeting Location: | Boston, MA |
| ISSN: | 1524-9557 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2007-01-01 |
| Start Page: | 882 |
| End Page: | 883 |
| Language: | English |
| ACCESSION: | WOS:000250396700099 |
| PROVIDER: | wos |
| DOI: | 10.1097/CJI.0b013e318158e4b5 |
| Notes: | --- - Meeting Abstract - 22nd Annual Scientific Meeting of the International-Society-for-Biological-Therapy-of-Cancer - NOV 02-04, 2007 - Boston, MA - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
